Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123361023 | 12336102 | 3 | F | 2016 | 20160706 | 20160505 | 20160712 | PER | US-PFIZER INC-2016244275 | PFIZER | 59.00 | YR | M | Y | 97.00000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123361023 | 12336102 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | M51573 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 123361023 | 12336102 | 2 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | |||||||
| 123361023 | 12336102 | 3 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | 0 | TABLET | |||||||||||
| 123361023 | 12336102 | 4 | C | ATIVAN | LORAZEPAM | 1 | 2 MG, 3X/DAY | 0 | 2 | MG | TID | ||||||||
| 123361023 | 12336102 | 5 | C | ATIVAN | LORAZEPAM | 1 | 1 MG, 4X/DAY (EVERY 6HRS) | 0 | 1 | MG | QID | ||||||||
| 123361023 | 12336102 | 6 | C | ATIVAN | LORAZEPAM | 1 | 6 MG, 2X/DAY (2MG IN MORNING AND 4MG AT BED TIME) | 0 | 6 | MG | BID | ||||||||
| 123361023 | 12336102 | 7 | C | INVOKANA | CANAGLIFLOZIN | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | QD | |||||||
| 123361023 | 12336102 | 8 | C | GLIPTIDE | 2 | 5 MG, 1X/DAY (IN THE MORNING) | 0 | 5 | MG | QD | |||||||||
| 123361023 | 12336102 | 9 | C | LEVEMIR | INSULIN DETEMIR | 1 | 55 UNITS AT BEDTIME | 0 | 55 | IU | QD | ||||||||
| 123361023 | 12336102 | 10 | C | LACTULOSE. | LACTULOSE | 1 | 15 ML, 1X/DAY (AT NIGHT) | 0 | 15 | ML | QD | ||||||||
| 123361023 | 12336102 | 11 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, 2X/DAY (25MG ONCE IN MORNING AND ONCE AT NIGHT PILL BY MOUTH) | 0 | 25 | MG | BID | |||||||
| 123361023 | 12336102 | 12 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | QD | |||||||
| 123361023 | 12336102 | 13 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 15 MG, 1X/DAY | 0 | 15 | MG | TABLET | QD | ||||||
| 123361023 | 12336102 | 14 | C | RANITIDINE HCL | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | 0 | 150 | MG | QD | |||||||
| 123361023 | 12336102 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 123361023 | 12336102 | 16 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 80 MG, 1X/DAY | 0 | 80 | MG | QD | |||||||
| 123361023 | 12336102 | 17 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 54 MG, 1X/DAY | 0 | 54 | MG | QD | |||||||
| 123361023 | 12336102 | 18 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 123361023 | 12336102 | 19 | C | TERAZOSIN HCL | TERAZOSIN HYDROCHLORIDE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 123361023 | 12336102 | 20 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 123361023 | 12336102 | 21 | C | PROMETHAZINE HCL | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, AS NEEDED (25 MG TABLET EVERY 12HRS AS NEEDED BY MOUTH) | 0 | 25 | MG | TABLET | |||||||
| 123361023 | 12336102 | 22 | C | ENULOSE | LACTULOSE | 1 | Oral | 15 ML, DAILY | 0 | 15 | ML | ||||||||
| 123361023 | 12336102 | 23 | C | OXYCODONE | OXYCODONE | 1 | 5 MG, AS NEEDED (TWICE A DAY) | 0 | 5 | MG | TABLET | ||||||||
| 123361023 | 12336102 | 24 | C | NOVOLIN | INSULIN HUMAN | 1 | 40 UNITS IN MORNING AND 30 UNITS AT NIGHT. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123361023 | 12336102 | 1 | Depression |
| 123361023 | 12336102 | 2 | Mood altered |
| 123361023 | 12336102 | 3 | Somatic symptom disorder |
| 123361023 | 12336102 | 4 | Anxiety |
| 123361023 | 12336102 | 7 | Diabetes mellitus |
| 123361023 | 12336102 | 8 | Diabetes mellitus |
| 123361023 | 12336102 | 9 | Diabetes mellitus |
| 123361023 | 12336102 | 10 | Ammonia increased |
| 123361023 | 12336102 | 11 | Hypertension |
| 123361023 | 12336102 | 12 | Anticoagulant therapy |
| 123361023 | 12336102 | 13 | Antiinflammatory therapy |
| 123361023 | 12336102 | 14 | Pancreatitis |
| 123361023 | 12336102 | 16 | Blood cholesterol increased |
| 123361023 | 12336102 | 17 | Pancreatic disorder |
| 123361023 | 12336102 | 18 | Hypertension |
| 123361023 | 12336102 | 19 | Prostatomegaly |
| 123361023 | 12336102 | 20 | Blood glucose abnormal |
| 123361023 | 12336102 | 21 | Nausea |
| 123361023 | 12336102 | 22 | Hepatomegaly |
| 123361023 | 12336102 | 23 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123361023 | 12336102 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123361023 | 12336102 | Chest pain | |
| 123361023 | 12336102 | Disturbance in attention | |
| 123361023 | 12336102 | Neuropathy peripheral | |
| 123361023 | 12336102 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123361023 | 12336102 | 1 | 201605 | 0 | ||
| 123361023 | 12336102 | 2 | 201502 | 0 | ||
| 123361023 | 12336102 | 4 | 2015 | 0 | ||
| 123361023 | 12336102 | 10 | 201504 | 0 | ||
| 123361023 | 12336102 | 14 | 2015 | 0 | ||
| 123361023 | 12336102 | 15 | 2015 | 0 | ||
| 123361023 | 12336102 | 17 | 2015 | 0 | ||
| 123361023 | 12336102 | 22 | 2015 | 0 | ||
| 123361023 | 12336102 | 23 | 2015 | 0 |